CYNOSURE INC
Healthcare · Electromedical & Electrotherapeutic Apparatus · SEC filings ↗ · Compare ⊕
Financials
SEC XBRL · annual| FY16 | FY15 | FY14 | FY13 | FY12 | FY11 | |
|---|---|---|---|---|---|---|
| Revenue | $94.7M | $74.9M | $292.4M | $226.0M | $153.5M | $110.6M |
| Operating income | $4.5M | $2.1M | $21.3M | −$5.8M | $12.1M | −$2.0M |
| Net income | $2.8M | −$8,000 | $31.3M | −$1.6M | $11.0M | −$2.9M |
| Total assets | $586.5M | $534.6M | $456.1M | $414.7M | $234.6M | $151.6M |
| Total liabilities | — | — | — | — | — | — |
| Equity | $455.5M | $404.4M | $358.1M | $328.4M | $197.5M | $119.6M |
| EPS (diluted) | $0.12 | $0.00 | $1.41 | $-0.09 | $0.79 | $-0.23 |
| Shares out. | 23.0M | 21.7M | 22.3M | 19.3M | 13.8M | 12.6M |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2016- Operating margin
- 4.7%
- Net margin
- 3.0%
- Return on equity
- 0.6%
- Return on assets
- 0.5%
- Return on capital (ROCE)
- 0.9%
- Liabilities / assets
- —
- Debt / equity
- —
- Book value / share
- $19.82
- Revenue growth (YoY)
- 26.4%
- Net income growth (YoY)
- —
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2016- Accruals / assets
- −7.2%clean
- Piotroski F-Score
- 7/8strong
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast. What these scores mean →
Signs
● 4 good- Operating margin is positive
- Revenue is growing year-over-year
- Positive operating cash flow
- Clean earnings (low accruals)
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
Insider transactions
SEC Form 4 · most recent| Insider | Date | Type | Shares | Price |
|---|---|---|---|---|
| Robinson Thomas HDirector | Mar 22, 2017 | U | 14,514 | $66.00 |
| Hatsopoulos MarinaDirector | Mar 22, 2017 | U | 18,850 | $66.00 |
| Flannery William O.Director | Mar 22, 2017 | U | 14,510 | $66.00 |
| Biagioni Ettore VDirector | Mar 22, 2017 | U | 9,510 | $66.00 |
| Barefoot Brian M.Director | Mar 22, 2017 | U | 15,850 | $66.00 |
| Delaney Douglas JOfficer — Chief Commercial Officer | Mar 22, 2017 | U | 15,438 | $66.00 |
| Webber Stephen J.Officer — Chief Financial Officer | Mar 22, 2017 | Grant | 23,180 | — |
| Davin Michael ROfficer — Chairman, President and CEO | Mar 22, 2017 | U | 38,625 | $66.00 |
| Robinson Thomas HDirector | Feb 11, 2017 | Option exercise | 1,271 | $0.00 |
| Hatsopoulos MarinaDirector | Feb 11, 2017 | Option exercise | 1,271 | $0.00 |
| Flannery William O.Director | Feb 11, 2017 | Option exercise | 1,271 | $0.00 |
| Delaney Douglas JOfficer — Chief Commercial Officer | Feb 10, 2017 | Option exercise | 3,750 | $0.00 |
Headline trade per Form 4 (officers, directors, 10%+ owners). Buy/sell read from the filing's structured data — blank where a field isn't cleanly tagged.
Material events
SEC Form 8-K · most recent- Completed an acquisition or disposition · Delisting / listing-standard notice · Modified shareholder rights · Change in control · Director / officer change · Amended charter or bylaws · Other material eventMar 23, 2017
- Director / officer changeFeb 22, 2017
- Entered a material agreement · Amended charter or bylaws · Other material eventFeb 14, 2017
- Results of operationsFeb 7, 2017
- Other material eventJan 27, 2017
- Director / officer changeDec 16, 2016
- Results of operationsOct 25, 2016
- Director / officer changeOct 21, 2016
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗- SC 13G/ASCHEDULE 13G/AFeb 9, 2018
- 15-12GApr 6, 2017
- EFFECTMar 29, 2017
- 4FORM 4 SUBMISSIONMar 24, 2017
- 4FORM 4 SUBMISSIONMar 24, 2017
- 4FORM 4 SUBMISSIONMar 24, 2017
- 4FORM 4 SUBMISSIONMar 24, 2017
- 4FORM 4 SUBMISSIONMar 24, 2017
- 4FORM 4 SUBMISSIONMar 24, 2017
- 4FORM 4 SUBMISSIONMar 24, 2017
- 4FORM 4 SUBMISSIONMar 24, 2017
- 8-KFORM 8-KMar 23, 2017
- S-8 POSMar 22, 2017
- S-8 POSMar 22, 2017
- S-8 POSMar 22, 2017
Event-driven situations (1)
Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.